{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:48:58Z","timestamp":1785408538217,"version":"3.56.0"},"reference-count":50,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2025-02219175"],"award-info":[{"award-number":["RS-2025-02219175"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"award":["RS-2025-02219175"],"award-info":[{"award-number":["RS-2025-02219175"]}],"id":[{"id":"https:\/\/ror.org\/00fdzyk40","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Ministry of Health & Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["RS-2025-02219175"],"award-info":[{"award-number":["RS-2025-02219175"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"award":["RS-2025-02219175"],"award-info":[{"award-number":["RS-2025-02219175"]}],"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by severe hepatic steatosis, lobular inflammation, and fibrosis. Although hesperidin, a citrus-derived flavanone, has been reported to exert metabolic and anti-inflammatory effects, its role in severe inflammatory and fibrotic conditions such as MASH remains incompletely understood. This study aimed to evaluate the effects of hesperidin in MASH using integrated in silico and in vivo approaches. Methods: Potential targets of hesperidin were identified using network pharmacology and molecular docking. For in vivo validation, C57BL\/6 mice were fed a methionine- and choline-deficient (MCD) diet for five weeks, with oral administration of hesperidin (150 or 300 mg\/kg\/day) starting from week two. The MCD model induces severe hepatic inflammation and fibrosis but does not fully reflect metabolic features such as obesity and insulin resistance. Hepatic histology, serum transaminases, immune cell populations, and hypothalamic neuroinflammatory markers were assessed. Results: In silico analyses suggested that hesperidin interacts with key regulators associated with MASH, including PPARG, TGFB1, and TNF. In the in vivo MCD-induced model, hesperidin treatment reduced hepatic lipid accumulation and collagen deposition, accompanied by significant decreases in serum ALT and AST levels (by approximately 30\u201334% and 42\u201353%, respectively, depending on dose). These effects were associated with downregulation of pro-inflammatory and pro-fibrogenic gene expression and increased expression of antioxidant markers. In addition, hesperidin decreased circulating Ly6Chigh monocytes and hepatic Kupffer cells, along with reduced hypothalamic microglial and astrocyte activation. Conclusions: Hesperidin attenuated key pathological features of MASH, including steatosis, inflammation, and fibrosis, and was associated with modulation of peripheral immune responses and central neuroinflammatory markers. These findings suggest that hesperidin may influence the liver\u2013immune\u2013brain axis and warrant further investigation in models that more closely reflect human metabolic conditions.<\/jats:p>","DOI":"10.3390\/nu18091402","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:31:56Z","timestamp":1777465916000},"page":"1402","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hesperidin Attenuates Experimental MASH by Modulating the Liver\u2013Immune\u2013Brain Axis: Integrated Evidence from Network Pharmacology and In Vivo Analysis"],"prefix":"10.3390","volume":"18","author":[{"given":"Seung-Hoon","family":"Yoo","sequence":"first","affiliation":[{"name":"Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4438-8093","authenticated-orcid":false,"given":"Ji-Han","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0910-4490","authenticated-orcid":false,"given":"Yeon-Joo","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2209-6229","authenticated-orcid":false,"given":"Byung-Cheol","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4093\/dmj.2024.0042","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality","volume":"49","author":"Oh","year":"2025","journal-title":"Diabetes Metab. J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gallo, G., Nalli, G., Baratta, F., Desideri, G., and Savoia, C. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26168081"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Huang, M., Chen, H., Wang, H., Wang, X., Wang, D., Li, Y., Zhou, Q., Zhang, D., Li, M., and Ma, L. (2024). Worldwide burden of liver cancer due to metabolic dysfunction-associated steatohepatitis from 1990 to 2019: Insights from the Global Burden of Disease study. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1424155"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e70132","DOI":"10.1002\/edm2.70132","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances","volume":"8","author":"Miller","year":"2025","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Xu, S., Zhang, Z., Zhou, Z., and Guo, J. (2026). Immune Determinants of MASLD Progression: From Immunometabolic Reprogramming to Fibrotic Transformation. Biology, 15.","DOI":"10.3390\/biology15020148"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jgh.16749","article-title":"Rodent model of metabolic dysfunction-associated fatty liver disease: A systematic review","volume":"40","author":"Cui","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.taap.2008.09.022","article-title":"Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice","volume":"234","author":"Gyamfi","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3727\/105221617X15093707969658","article-title":"Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights","volume":"18","author":"Stephenson","year":"2018","journal-title":"Gene Expr."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wei, L., Gao, C., and Qin, H. (2026). Comparison and Characteristics of MASLD Mouse Models. Biomedicines, 14.","DOI":"10.3390\/biomedicines14040895"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.pharmr.2024.100018","article-title":"Pharmacological treatment for metabolic dysfunction-associated steatotic liver disease and related disorders: Current and emerging therapeutic options","volume":"77","author":"Zhang","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"108967","DOI":"10.1016\/j.jnutbio.2022.108967","article-title":"Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms","volume":"104","author":"Yang","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pyrzynska, K. (2022). Hesperidin: A Review on Extraction Methods, Stability and Biological Activities. Nutrients, 14.","DOI":"10.3390\/nu14122387"},{"key":"ref_13","first-page":"1934578X251407789","article-title":"Hesperidin as an Emerging Nutraceutical for Management of Diverse Metabolic Syndrome: A Narrative Review on in vivo and in silico Experiments","volume":"21","author":"Aja","year":"2026","journal-title":"Nat. Prod. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e16031","DOI":"10.1016\/j.heliyon.2023.e16031","article-title":"Assessing the hepatoprotective effects of hesperidin on liver-associated disorders in albino rats with experimentally induced obesity and type II diabetes: A histological and biochemical study","volume":"9","author":"Atta","year":"2023","journal-title":"Heliyon"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Dungubat, E., Fujikura, K., Kuroda, M., Fukusato, T., and Takahashi, Y. (2025). Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review. Nutrients, 17.","DOI":"10.3390\/nu17132211"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107615","DOI":"10.1016\/j.phrs.2025.107615","article-title":"High-fat diet and neuroinflammation: The role of mitochondria","volume":"212","author":"Song","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"159570","DOI":"10.1016\/j.bbalip.2024.159570","article-title":"Hesperitin prevents non-alcoholic steatohepatitis by modulating mitochondrial dynamics and mitophagy via the AMPKalpha-Drp1\/PINK1-Parkin signaling pathway","volume":"1870","author":"Chen","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bai, W., and Zhu, Z. (2025). Multiorgan crosstalk in MASLD\/MASH: From hepatic pathogenesis to systemic complications. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1720780"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"949157","DOI":"10.1155\/2012\/949157","article-title":"Innate immune cells in liver inflammation","volume":"2012","author":"Liaskou","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hashimoto, K., Gotoh, M., and Ikeshima-Kataoka, H. (2025). Astrocytic and microglial cell functions in neuroinflammatory diseases and their animal models. Front. Cell Neurosci., 19.","DOI":"10.3389\/fncel.2025.1708775"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhu, Y., and Cai, B. (Trends Endocrinol. Metab., 2025). Mechanisms and therapeutic insights into MASH-associated fibrosis, Trends Endocrinol. Metab., in press.","DOI":"10.1016\/j.tem.2025.09.004"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xu, Y., He, P., He, B., and Chen, Z. (2025). Bioactive flavonoids metabolites in citrus species: Their potential health benefits and medical potentials. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1552171"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"110069","DOI":"10.1016\/j.jnutbio.2025.110069","article-title":"Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila","volume":"146","author":"Xu","year":"2025","journal-title":"J. Nutr. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"120428","DOI":"10.1016\/j.lfs.2022.120428","article-title":"Hesperidin attenuates hepatic lipid accumulation in mice fed high-fat diet and oleic acid induced HepG2 via AMPK activation","volume":"296","author":"Chen","year":"2022","journal-title":"Life Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"E163","DOI":"10.1152\/ajpendo.00023.2018","article-title":"Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis","volume":"315","author":"Kalavalapalli","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1523-1755.2004.00600.x","article-title":"Utility of endogenous creatinine clearance as a measure of renal function in mice","volume":"65","author":"Dunn","year":"2004","journal-title":"Kidney Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1194\/jlr.M800411-JLR200","article-title":"Genetic basis of HDL variation in 129\/SvImJ and C57BL\/6J mice: Importance of testing candidate genes in targeted mutant mice","volume":"50","author":"Su","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"29477","DOI":"10.1074\/jbc.M003523200","article-title":"Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo","volume":"275","author":"Kawano","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Arabi, Y.M., Tamimi, W., Jones, G., Jawdat, D., Tamim, H., Al-Dorzi, H.M., Sadat, M., Afesh, L., Sakhija, M., and Al-Dawood, A. (2019). Free Fatty Acids\u2019 Level and Nutrition in Critically Ill Patients and Association with Outcomes: A Prospective Sub-Study of PermiT Trial. Nutrients, 11.","DOI":"10.3390\/nu11020384"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"159545","DOI":"10.1016\/j.bbalip.2024.159545","article-title":"A methionine-choline-deficient diet induces nonalcoholic steatohepatitis and alters the lipidome, metabolome, and gut microbiome profile in the C57BL\/6J mouse","volume":"1869","author":"Gautam","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.ajpath.2021.06.010","article-title":"Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis Is Associated with Increased Intestinal Inflammation","volume":"191","author":"Matthews","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Duan, Y., Zeng, L., Zheng, C., Song, B., Li, F., Kong, X., and Xu, K. (2018). Inflammatory Links Between High Fat Diets and Diseases. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02649"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101196","DOI":"10.1016\/j.jhepr.2024.101196","article-title":"Understanding the complex macrophage landscape in MASLD","volume":"6","author":"Liu","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hosawi, S. (2023). Current Update on Role of Hesperidin in Inflammatory Lung Diseases: Chemistry, Pharmacology, and Drug Delivery Approaches. Life, 13.","DOI":"10.3390\/life13040937"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sudhakaran, M., and Doseff, A.I. (2020). The Targeted Impact of Flavones on Obesity-Induced Inflammation and the Potential Synergistic Role in Cancer and the Gut Microbiota. Molecules, 25.","DOI":"10.3390\/molecules25112477"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40104-026-01372-4","article-title":"Hesperidin alleviates systemic inflammation and oxidative stress by remodeling adipose tissue lipid metabolism in periparturient dairy cows","volume":"17","author":"Tan","year":"2026","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","article-title":"Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C","volume":"26","author":"Tanwar","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.redox.2014.09.004","article-title":"Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling","volume":"3","author":"Schattenberg","year":"2014","journal-title":"Redox Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"105401","DOI":"10.1016\/j.msard.2023.105401","article-title":"The protective effects of hesperidin as an antioxidant against quinolinic acid-induced toxicity on oligodendroglia cells: An in vitro study","volume":"82","author":"Amiri","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1017\/S0954422424000350","article-title":"A comprehensive review on the impact of hesperidin and its aglycone hesperetin on metabolic dysfunction-associated steatotic liver disease and other liver disorders","volume":"38","author":"Sivaslioglu","year":"2025","journal-title":"Nutr. Res. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.14348\/molcells.2022.2044","article-title":"Role of Hypothalamic Reactive Astrocytes in Diet-Induced Obesity","volume":"45","author":"Sa","year":"2022","journal-title":"Mol. Cells"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2013.10.009","article-title":"Liver-brain interactions in inflammatory liver diseases: Implications for fatigue and mood disorders","volume":"35","author":"Swain","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yang, X., Qiu, K., Jiang, Y., Huang, Y., Zhang, Y., and Liao, Y. (2024). Metabolic Crosstalk between Liver and Brain: From Diseases to Mechanisms. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147621"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40199-020-00344-x","article-title":"A review of the hepatoprotective effects of hesperidin, a flavanon glycoside in citrus fruits, against natural and chemical toxicities","volume":"28","author":"Tabeshpour","year":"2020","journal-title":"Daru"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Merecz-Sadowska, A., Sadowski, A., Zielinska-Blizniewska, H., Zajdel, K., and Zajdel, R. (2025). Network Pharmacology as a Tool to Investigate the Antioxidant and Anti-Inflammatory Potential of Plant Secondary Metabolites-A Review and Perspectives. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26146678"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbadis.2014.02.012","article-title":"Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH)","volume":"1842","author":"Jha","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Choi, S.S., Lee, S.H., and Lee, K.A. (2022). A Comparative Study of Hesperetin, Hesperidin and Hesperidin Glucoside: Antioxidant, Anti-Inflammatory, and Antibacterial Activities In Vitro. Antioxidants, 11.","DOI":"10.3390\/antiox11081618"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ptr.5256","article-title":"Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models","volume":"29","author":"Parhiz","year":"2015","journal-title":"Phytother. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"G749","DOI":"10.1152\/ajpgi.00184.2011","article-title":"Liver-brain inflammation axis","volume":"301","author":"Swain","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/9\/1402\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:46:13Z","timestamp":1777466773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/9\/1402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["nu18091402"],"URL":"https:\/\/doi.org\/10.3390\/nu18091402","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}